Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if TARS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
45 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 28 days ago
Red flags: 0
257 filers reported a long position in TARS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $242.7M | 3.9M | +8.5% |
| Deep Track Capital, LP | $230.8M | 3.7M | +1.9% |
| RTW INVESTMENTS, LP | $211.3M | 3.4M | +0.3% |
| Jupiter Topco LLC | $176.8M | 2.8M | — |
| Paradigm Biocapital Advisors LP | $174.7M | 2.8M | +8.3% |
| MORGAN STANLEY | $115M | 1.8M | -6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $112.9M | 1.8M | +1.8% |
| JENNISON ASSOCIATES LLC | $104.7M | 1.7M | -2.8% |
| TANG CAPITAL MANAGEMENT LLC | $98.7M | 1.6M | +31.9% |
| MILLENNIUM MANAGEMENT LLC | $89.8M | 1.4M | +152.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.